The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study

17 of 35 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Head and Neck Neoplasms; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Adult; Aged; Middle Aged; Female; Male; Squamous Cell Carcinoma of Head and Neck; Progression-Free Survival
PubMed ID
42218660
PubMed Central ID
PMC13489780
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal